Showing results (311-320 of 2,229) with videos related to

Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|April 29, 2010
Gene expression of somatostatin receptor 4 predicts clinical outcome of patients with metastatic neuroendocrine tumors treated with somatostatin analogsOndrej Slaby, Milana Sachlova, Marketa Bednarikova, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancerJózsef Horti, Anders Widmark, Arnulf Stenzl, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody capM Jules Mattes, Rosana B Michel, David M Goldenberg, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
Tumor accumulation of radiolabeled bevacizumab due to targeting of cell- and matrix-associated VEGF-A isoformsThamar H Stollman, Marian G W Scheer, Gerben M Franssen, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
Intracranial tumors after radiation therapy: role of 99mTc-tetrofosmin SPECT/CT with a hybrid cameraLuca Filippi, Riccardo Santoni, Pompeo Nicolì, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
The role of dosimetry in the high activity 90Y-ibritumomab tiuxetan regimens: two cases of abnormal biodistributionDemetrio Aricò, Chiara Maria Grana, Anna Vanazzi, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 23, 2009
Synergistic effect of diosmin and interferon-alpha on metastatic pulmonary melanomaNuria Alvarez, Vicente Vicente, Cristina Martínez
Cancer Biotherapy & Radiopharmaceuticals|August 22, 2009
Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient studyYuni K Dewaraja, Scott J Wilderman, Kenneth F Koral, et al.
Pageof 223